Materials and methods for detection of Oxalobacter formigenes

• US 6,709,820 B2
• Filed: 04/09/2001
• Issued: 03/23/2004
• Est. Priority Date: 06/20/1994
• Status: Expired due to Fees

• Current Assignee: University of Florida Research Foundation, Incorporated (State University System of Florida)
• Original Assignee: University of Florida Research Foundation, Incorporated (State University System of Florida)
• Inventors: Sidhu, Harmeet, Peck, Ammon B.
• Primary Examiner(s): Riley, Jezia
• Application Number:
  US09/829,094
• Publication Number:
  US 20020081681A1
• Time in Patent Office: 1,079 Days
• Field of Search: 435/6, 435/91.1, 435/91.2, 536/23.1, 536/24.3, 536/24.33
• US Class Current: 435/6.14
• CPC Class Codes: C12N 9/10 Transferases (2.) ribonucleases C12N9/22
• CPC Class Codes: C12N 9/1014 Hydroxymethyl-, formyl-transferases (2.1.2)
• CPC Class Codes: C12N 9/1022 transferring aldehyde or ketonic groups (2.2)
• CPC Class Codes: C12N 9/88 Lyases (4.)
• CPC Class Codes: C12Q 1/04 Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor C12Q1/6897 takes precedence
• CPC Class Codes: C12Q 1/48 involving transferase
• CPC Class Codes: C12Q 1/527 involving lyase
• CPC Class Codes: C12Q 1/689 for bacteria
• CPC Class Codes: G01N 2333/9104 Aldehyde and ketone transferases (2.2)
• CPC Class Codes: G01N 2333/988 Lyases (4.), e.g. aldolases, heparinase, enolases, fumarase

Abstract

The subject invention concerns the novel use of formyl-CoA transferase enzyme together with oxalyl-CoA decarboxylase enzyme for the detection and measurement of oxalate in biological samples. The use of the enzyme system according to the subject invention results in the conversion of oxalate into carbon dioxide and formate. Because the production of formate is directly correlated to the concentration of oxalate present in a sample, the determination of the resulting formate concentration provides an accurate, sensitive and rapid means for detecting even low levels of oxalate. The subject invention further concerns the cloning, sequencing and expression of the genes that encode the formyl-CoA transferase enzyme and the oxalyl-CoA decarboxylase enzyme of Oxalobacter formigenes. The subject invention also concerns methods for detecting the presence of Oxalobacter formigenes organisms in a sample, and the polynucleotide probes and primers used in the detection method.

Claims

1. A method for detecting Oxalobacter formigenes in a sample, comprising the steps of:

(a) contacting said sample with a polynucleotide probe under conditions sufficient for selective hybridization of said polynucleotide probe with DNA of Oxalobacter formigenes that comprises a nucleotide sequence of an oxalyl-CoA decarboxylase gene, wherein said polynucleotide probe is substantially complementary with a nucleotide sequence of an oxalyl-CoA decarboxylase gene of Oxalobacter formigenes; and

(b) detecting said probe hybridized to said DNA.

2. The method according to claim 1, wherein said polynucleotide probe or said DNA is immobilized on a solid phase matrix prior to performing step (a).

3. The method according to claim 1, wherein said solid phase matrix is selected from the group consisting of paper, nitrocellulose, nylon, PVDF, and plastic.

4. The method according to claim 1, wherein said polynucleotide probe is labeled with a detectable label.

5. The method according to claim 4, wherein said detectable label is selected from the group consisting of a radioisotope, fluorophore, chemiluminescent molecule, and an enzyme.

6. The method according to claim 4, wherein said polynucleotide probe is labeled with fluorescein, rhodamine, luciferin, or luminol.

7. The method according to claim 5, wherein said enzyme is selected from the group consisting of horseradish peroxidase and alkaline phosphatase.

8. The method according to claim 1, wherein said polynucleotide probe is conjugated with a ligand, hapten, or antigenic determinant.

9. The method according to claim 8, wherein prior to step (b), said polynucleotide probe is contacted with a molecule that binds to said ligand, hapten, or antigenic determinant, wherein said molecule is detectably labeled.

10. The method according to claim 9, wherein said detectable label is selected from the group consisting of radioisotope, fluorophore, chemiluminescent molecule, and an enzyme.

11. The method according to claim 1, wherein said polynucleotide probe comprises a nucleotide sequence selected from the group consisting of SEQ ID NO. 5, SEQ ID NO. 6, SEQ ID NO. 9, SEQ ID NO. 14, SEQ ID NO. 15, and SEQ ID NO. 16, or a fragment of said nucleotide sequence which can selectively hybridize with DNA of Oxalobacter formigenes in step (a).

12. The method according to claim 1, wherein said polynucleotide probe comprises the nucleotide sequence of SEQ ID NO. 14.

38. The method according to claim 1, further comprising after step (a), a washing step to remove non-hybridized material.

39. The method according to claim 1, wherein said sample is treated to fragment DNA in said sample prior to contact with said polynucleotide probe.

40. The method according to claim 39, wherein DNA in said sample is fragmented by contacting said sample with a restriction endonuclease.

41. The method according to claim 1, wherein said sample is a biological sample.

42. The method according to claim 41, wherein said biological sample is selected from the group consisting of biopsy, fecal matter, and tissue scrapings.

43. The method according to claim 1, wherein said sample is treated to isolate DNA from organisms present in said sample.

13. A method for detecting Oxalobacter formigenes in a sample, comprising the steps of:

(a) amplifying DNA of Oxalobacter formigenes by polymerase chain reaction (PCR) using a polynucleotide PCR primer, wherein said primer is substantially complementary with a polynucleotide sequence comprising an oxalyl-CoA decarboxylase gene of Oxalobacter formigenes;

(b) contacting said amplified DNA with a polynucleotide probe under conditions sufficient for selective hybridization of said polynucleotide probe with DNA of Oxalobacter formigenes that comprises a nucleotide sequence of an oxalyl-CoA decarboxylase gene, wherein said polynucleotide probe is substantially complementary with a nucleotide sequence of an oxalyl-CoA decarboxylase gene of Oxalobacter formigenes; and

(c) detecting said probe hybridized to said DNA.

14. The method according to claim 13, wherein said amplified DNA is immobilized on a solid phase matrix prior to performing step (b).

15. The method according to claim 13, wherein said polynucleotide probe is immobilized as a solid phase matrix prior to performing step (b).

16. The method according to claim 13, wherein said primer comprises a nucleotide sequence selected from the group consisting of SEQ ID NO. 6, SEQ ID NO. 7, SEQ ID NO. 8, SEQ ID NO. 9, SEQ ID NO. 11, SEQ ID NO. 12, SEQ ID NO. 13, and SEQ ID NO. 17, or a fragment of said nucleotide sequence which can prime said PCR amplification in step (a).

17. The method according to claim 13, wherein said primer comprises a nucleotide sequence selected from the group consisting of SEQ ID NO. 12 and SEQ ID NO. 13.

18. The method according to claim 14, wherein said solid phase matrix is selected from the group consisting of paper, nitrocellulose, nylon, PVDF, and plastic.

19. The method according to claim 15, wherein said solid phase matrix is selected from the group consisting of paper, nitrocellulose, nylon, PVDF, and plastic.

20. The method according to claim 13, wherein said polynucleotide probe is labeled with a detectable label.

21. The method according to claim 20, wherein said detectable label is selected from the group consisting of a radioisotope, fluorophore, chemiluminescent molecule, and an enzyme.

22. The method according to claim 21, wherein said enzyme is selected from the group consisting of horseradish peroxidase and alkaline phosphatase.

23. The method according to claim 13, wherein said polynucleotide probe is conjugated with a ligand, hapten, or antigenic determinant.

24. The method according to claim 23, wherein prior to step (b), said polynucleotide probe is contacted with a molecule that binds to said ligand, hapten, or antigenic determinant, wherein said molecule is detectably labeled.

25. The method according to claim 24, wherein said detectable label is selected from the group consisting of radioisotope, fluorophore, chemiluminescent molecule, and an enzyme.

26. The method according to claim 13, wherein said PCR primer is labeled with a detectable label.

27. The method according to claim 26, wherein said detectable label is selected from the group consisting of a radioisotope, fluorophore, chemiluminescent molecule, and an enzyme.

28. The method according to claim 13, wherein said PCR primer is conjugated with a ligand, hapten, or antigenic determinant.

29. The method according to claim 28, wherein prior to step (c), said PCR primer is contacted with a molecule that binds to said ligand, hapten, or antigenic determinant, wherein said molecule is detectably labeled.

30. The method according to claim 29, wherein said detectable label is selected from the group consisting of radioisotope, fluorophore, chemiluminescent molecule, and an enzyme.

31. The method according to claim 13, wherein said polynucleotide probe comprises a nucleotide sequence selected from the group consisting of SEQ ID NO. 5, SEQ ID NO. 6, SEQ ID NO. 9, SEQ ID NO. 14, SEQ ID NO. 15, and SEQ ID NO. 16, or a fragment of said nucleotide sequence which can selectively hybridize with DNA of Oxalobacter formigenes in step (b).

32. The method according to claim 13, wherein said polynucleotide probe comprises the nucleotide sequence of SEQ ID NO. 14.

44. The method according to claim 13, further comprising after step (b), a washing step to remove non-hybridized material.

45. The method according to claim 13, wherein said sample is treated to fragment DNA in said sample prior to contact with said polynucleotide probe or amplification with said polynucleotide PCR primer.

46. The method according to claim 45, wherein DNA in said sample is fragmented by contacting said sample with a restriction endonuclease.

47. The method according to claim 13, wherein said sample is a biological sample.

48. The method according to claim 47, wherein said biological sample is selected from the group consisting of biopsy, fecal matter, and tissue scrapings.

49. The method according to claim 13, wherein said sample is treated to isolate DNA from organisms present in said sample.

33. A polynucleotide probe that selectively hybridizes with DNA of Oxalobacter formigenes, comprising a nucleotide sequence that is substantially complementary with a polynucleotide sequence present in an Oxalobacter formigenes genome, wherein the polynucleotide sequence present in the Oxalobacter formigenes genome comprises a gene selected from the group consisting of the formyl-CoA transferase gene and the oxalyl-CoA decarboxylase gene.

36. A kit for detecting the presence of Oxalobacter formigenes in a sample, comprising in one or more separate containers:

(a) the polynucleotide probe according to claim 33.

37. The kit, according to claim 36, further comprising:

(b) an oligonucleotide comprising a nucleotide sequence that is substantially complementary with a polynucleotide sequence present in an Oxalobacter formigenes genome, wherein said polynucleotide sequence present in said Oxalobacter formigenes genome comprises a gene selected from the group consisting of the formyl-CoA transferase gene and the oxalyl-CoA decarboxylase gene, and wherein said oligonucleotide is capable of priming polymerase chain reaction amplification of said polynucleotide sequence present in said Oxalobacter formigenes genome.

34. The polynucleotide probe, according to clam 33, wherein said polynucleotide probe hybridizes under high-stringency conditions with a nucleotide sequence of said formyl-CoA transferase gene or said oxalyl-CoA decarboxylase gene.

35. An oligonucleotide comprising a nucleotide sequence that is substantially complementary with a polynucleotide sequence present in an Oxalobacter formigenes genome, wherein said polynucleotide sequence present in said Oxalobacter formigenes genome comprises a gene selected from the group consisting of the formyl-CoA transferase gene and the oxalyl-CoA decarboxylase gene, and wherein said oligonucleotide is capable of priming polymerase chain reaction amplification of said polynucleotide sequence present in said Oxalobacter formigenes genome.